Contributor contact details |
|
xi | |
Foreword |
|
xv | |
|
|
Part I Introduction to minimized cardiopulmonary bypass |
|
|
1 | (112) |
|
1 Historical development of minimised cardiopulmonary bypass |
|
|
3 | (14) |
|
|
1.1 Introduction and historical perspective |
|
|
3 | (1) |
|
1.2 Cardiopulmonary bypass: from pioneering to refinement |
|
|
4 | (3) |
|
1.3 Cardiopulmonary bypass: does size matter? |
|
|
7 | (5) |
|
|
12 | (1) |
|
|
13 | (4) |
|
2 Anticoagulation protocols for minimized cardiopulmonary bypass |
|
|
17 | (18) |
|
|
2.1 Introduction: blood activation during cardiac surgery with cardiopulmonary bypass (CPB) |
|
|
17 | (3) |
|
2.2 Anticoagulation during CPB: basic principles and historical notes |
|
|
20 | (3) |
|
2.3 Heparin-bonded surfaces and other biocompatible treatments |
|
|
23 | (1) |
|
2.4 Reduced systemic heparinization (RSH) |
|
|
23 | (5) |
|
|
28 | (1) |
|
|
29 | (1) |
|
|
30 | (5) |
|
3 Minimized extracorporeal circulation: physiology and pathophysiology |
|
|
35 | (10) |
|
|
|
|
3.1 Introduction: basic principles |
|
|
35 | (2) |
|
3.2 The inflammatory cascade and biomarkers |
|
|
37 | (5) |
|
|
42 | (1) |
|
|
42 | (3) |
|
4 Blood--surface interface in miniaturised extracorporeal circulation systems |
|
|
45 | (17) |
|
|
|
|
45 | (1) |
|
4.2 Blood--surface contact in cardiopulmonary bypass (CPB) |
|
|
46 | (4) |
|
4.3 Clinical benefits of miniaturised extracorporeal circulation systems |
|
|
50 | (6) |
|
|
56 | (6) |
|
5 Hemodilution: physiology and pathophysiology |
|
|
62 | (24) |
|
|
|
62 | (1) |
|
5.2 Basic physiology and pathophysiology of hemodilution |
|
|
63 | (3) |
|
5.3 Microvascular alterations with hemodilution |
|
|
66 | (1) |
|
5.4 Hemodilution and cardiopulmonary bypass (CPB) |
|
|
67 | (3) |
|
5.5 Determinants of tissue oxygenation -- functional capillary density (FCD) |
|
|
70 | (5) |
|
|
75 | (1) |
|
|
76 | (10) |
|
6 Inflammatory response and minimized cardiopulmonary bypass |
|
|
86 | (27) |
|
|
|
|
86 | (1) |
|
6.2 Cardiopulmonary bypass (CPB)-induced inflammatory cascade |
|
|
87 | (6) |
|
6.3 Pharmacological antioxidants for CPB: impact on biochemical and clinical outcomes |
|
|
93 | (6) |
|
6.4 Minimized CPB circuits |
|
|
99 | (3) |
|
|
102 | (1) |
|
|
102 | (10) |
|
6.7 Appendix: abbreviations |
|
|
112 | (1) |
|
Part II Minimized cardiopulmonary bypass equipment |
|
|
113 | (42) |
|
7 Design and principles of the minimized extracorporeal circuit |
|
|
115 | (18) |
|
|
|
|
|
115 | (1) |
|
7.2 Basic principles of minimized extracorporeal circulation |
|
|
116 | (1) |
|
7.3 Evolution of minimized circuits |
|
|
116 | (1) |
|
7.4 Minimized extracorporeal systems currently available |
|
|
117 | (9) |
|
7.5 Surgical applications of minimized extracorporeal circulation |
|
|
126 | (1) |
|
7.6 Controversies and challenges facing minimized cardiopulmonary bypass |
|
|
127 | (1) |
|
7.7 Future trends in minimized cardiopulmonary bypass |
|
|
128 | (1) |
|
|
129 | (4) |
|
8 Cardiopulmonary bypass perfusate |
|
|
133 | (8) |
|
|
|
133 | (1) |
|
|
133 | (1) |
|
8.3 Types of crystalloids and colloid agents used in prime |
|
|
134 | (1) |
|
8.4 Pharmacological agents used in prime |
|
|
135 | (1) |
|
8.5 Using prime in CPB procedures |
|
|
136 | (1) |
|
8.6 Examples of prime combinations |
|
|
137 | (1) |
|
8.7 Minimizing the use of prime |
|
|
138 | (1) |
|
|
139 | (1) |
|
|
139 | (2) |
|
9 Myocardial preservation techniques for mini-bypass |
|
|
141 | (14) |
|
|
|
|
141 | (1) |
|
9.2 Methods of myocardial protection |
|
|
142 | (5) |
|
9.3 Myocardial protection in mini-bypass |
|
|
147 | (2) |
|
|
149 | (1) |
|
|
150 | (5) |
|
Part III Clinical applications of minimized cardiopulmonary bypass |
|
|
155 | (90) |
|
10 Minimised cardiopulmonary bypass: objectives and indications |
|
|
157 | (19) |
|
|
|
10.1 Introduction: objectives of minimised cardiopulmonary bypass |
|
|
157 | (12) |
|
10.2 Indications and patient selection |
|
|
169 | (3) |
|
|
172 | (1) |
|
|
172 | (4) |
|
11 Coronary artery bypass grafting (CABG) |
|
|
176 | (13) |
|
|
|
|
176 | (1) |
|
11.2 History of coronary artery bypass grafting (CABG) |
|
|
177 | (3) |
|
11.3 Patient selection (indications) for mini-invasive cardiopulmonary bypass |
|
|
180 | (3) |
|
|
183 | (1) |
|
11.5 Anastomoses techniques |
|
|
184 | (1) |
|
11.6 Surgical management on mini-invasive cardiopulmonary bypass |
|
|
185 | (1) |
|
|
186 | (1) |
|
|
187 | (2) |
|
12 Valve surgery using minimized perfusion circuits |
|
|
189 | (7) |
|
|
|
|
189 | (1) |
|
12.2 Surgical and technical aspects |
|
|
189 | (2) |
|
12.3 Blood management and patient treatment in valve surgery |
|
|
191 | (2) |
|
12.4 Experience with closed-loop perfusion circuits in valve surgery |
|
|
193 | (1) |
|
|
193 | (3) |
|
13 Minimising cardiopulmonary bypass in children |
|
|
196 | (23) |
|
|
|
|
196 | (1) |
|
13.2 Challenges of cardiopulmonary bypass (CPB) in the congenital patient |
|
|
197 | (2) |
|
13.3 Potential goals of mini-CPB |
|
|
199 | (3) |
|
13.4 Mini-CPB and neurological outcome |
|
|
202 | (1) |
|
13.5 Mini-CPB circuit design options in congenital heart surgery |
|
|
203 | (9) |
|
|
212 | (1) |
|
13.7 Alternative procedures to CPB |
|
|
212 | (1) |
|
|
213 | (1) |
|
|
213 | (5) |
|
13.10 Appendix: abbreviations |
|
|
218 | (1) |
|
14 Comparison of minimized circulation with off-pump coronary artery bypass (OPCAB) grafting and conventional surgery |
|
|
219 | (10) |
|
|
|
|
|
219 | (2) |
|
14.2 Controversies and challenges facing off-pump coronary artery bypass (OPCAB) grafting |
|
|
221 | (2) |
|
14.3 Studies comparing OPCAB with mini-cardiopulmonary bypass (mini-CPB) and mini-CPB assisted OPCAB |
|
|
223 | (2) |
|
14.4 Future trends and competition between OPCAB and minimized cardiopulmonary bypass |
|
|
225 | (1) |
|
|
226 | (3) |
|
15 Minimally invasive cardiac surgery, port-access and robotic surgery |
|
|
229 | (16) |
|
|
|
|
229 | (1) |
|
15.2 Minimally invasive coronary artery bypass grafting |
|
|
229 | (5) |
|
15.3 Minimally invasive valve surgery |
|
|
234 | (2) |
|
15.4 Minimally invasive congenital surgery |
|
|
236 | (1) |
|
15.5 Minimally invasive treatment of atrial fibrillation |
|
|
237 | (1) |
|
15.6 Miscellaneous possibilities of minimally invasive surgery |
|
|
238 | (1) |
|
|
238 | (2) |
|
|
240 | (1) |
|
|
240 | (5) |
Index |
|
245 | |